cimb-logo

Journal Browser

Journal Browser

Network Pharmacology, Multi-targets and Receptor–Receptor Interactions in the CNS

A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Pharmacology".

Deadline for manuscript submissions: 31 March 2025 | Viewed by 2466

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genova, Viale Cembrano 4, 16148 Genova, Italy
Interests: neuroscience; neurotransmitters and gliotransmitters; exosomes; glial cells; receptor heterodimerization

E-Mail Website
Guest Editor
Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genoa, 16148 Genoa, Italy
Interests: Alzheimer’s disease, animal behaviour, receptor-receptor interaction, nicotinic receptors, muscarinic receptors
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Network pharmacology, multi-targets and receptor–receptor interactions in the CNS are three keys to future drug therapy in CNS.

Recent advances have highlighted the limitations of the traditional 'one-to-one' therapeutic approach, where a single molecule targets a specific protein in the central nervous system (CNS). As in vitro and in vivo techniques have improved, we have gained a deeper understanding of the intricate network of interactions among target proteins. This dynamic interplay requires a comprehensive assessment of the physiological and pathological conditions that may influence these interactions. To address these challenges, modern approaches such as network pharmacology, multi-targeting, and receptor–receptor interactions offer promising solutions. This Special Issue aims to integrate information from articles and reviews focusing on topics such as:

  • Network pharmacology in the CNS;
  • Polypharmacology in the CNS;
  • Multi-targets in the CNS;
  • Phytocomplexes and pharmacological activities in the CNS;
  • Receptor–receptor interactions in the CNS;
  • Crosstalk in the CNS.

Dr. Chiara Cervetto
Dr. Massimo Grilli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • network pharmacology
  • multi-targets
  • receptor–receptor interactions
  • target proteins
  • drug therapy in CNS
  • receptors

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

19 pages, 2028 KiB  
Review
Orphan GPCRs in Neurodegenerative Disorders: Integrating Structural Biology and Drug Discovery Approaches
by Jinuk Kim and Chulwon Choi
Curr. Issues Mol. Biol. 2024, 46(10), 11646-11664; https://doi.org/10.3390/cimb46100691 - 19 Oct 2024
Viewed by 2159
Abstract
Neurodegenerative disorders, particularly Alzheimer’s and Parkinson’s diseases, continue to challenge modern medicine despite therapeutic advances. Orphan G-protein-coupled receptors (GPCRs) have emerged as promising targets in the central nervous system, offering new avenues for drug development. This review focuses on the structural biology of [...] Read more.
Neurodegenerative disorders, particularly Alzheimer’s and Parkinson’s diseases, continue to challenge modern medicine despite therapeutic advances. Orphan G-protein-coupled receptors (GPCRs) have emerged as promising targets in the central nervous system, offering new avenues for drug development. This review focuses on the structural biology of orphan GPCRs implicated in these disorders, providing a comprehensive analysis of their molecular architecture and functional mechanisms. We examine recent breakthroughs in structural determination techniques, such as cryo-electron microscopy and X-ray crystallography, which have elucidated the intricate conformations of these receptors. The review highlights how structural insights inform our understanding of orphan GPCR activation, ligand binding and signaling pathways. By integrating structural data with molecular pharmacology, we explore the potential of structure-guided approaches in developing targeted therapeutics toward orphan GPCRs. This structural-biology-centered perspective aims to deepen our comprehension of orphan GPCRs and guide future drug discovery efforts in neurodegenerative disorders. Full article
Show Figures

Figure 1

Back to TopTop